Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Linking the Gut Microbiota to the Prognosis of Glioblastoma Multiforme

NCT03631823 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT03631823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03631823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Linking the Gut Microbiota to the Prognosis of Glioblastoma Multiforme
Lead sponsor
Huashan Hospital
Phase
Observational
Overall status
Unknown status
Start date
August 10, 2018
Completion date
May 1, 2020
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gut microbiota, glioblastoma multiforme, microglia, tumor related macrophagocyte, prognosis